SCM
ALNY icon

Sterling Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sterling Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
5,182
+1,625
+46% +$553K 0.03% 365
2025
Q4 		$1.41M Buy
3,557
+730
+26% +$323K 0.02% 527
2025
Q3 		$1.29M Sell
2,827
-9,262
-77% -$3.77M 0.02% 555
2025
Q2 		$3.94M Sell
12,089
-1,008
-8% -$279K 0.06% 234
2025
Q1 		$3.54M Sell
13,097
-4,990
-28% -$1.28M 0.05% 236
2024
Q4 		$4.26M Buy
18,087
+15,507
+601% +$4.08M 0.06% 254
2024
Q3 		$710K Buy
+2,580
New +$672K 0.01% 704
2015
Q3 		– Sell
-9,205
Closed -$1.1M – 961
2015
Q2 		$1.1M Sell
9,205
-334
-4% -$39.9K 0.01% 429
2015
Q1 		$996K Buy
+9,539
New +$967K 0.01% 449

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return